By Ben GlickmanShares of Axonics rose on Monday after the company agreed be acquired for $3.7 billion in cash by Boston Scientific. The stock was up 20% to $69.25, its highest intraday level since December 2022. Shares are up about 26% in the last year.

Source: Wall Street Journal January 08, 2024 22:08 UTC